American Healthcare REIT, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-81.5% vs price
Base Case (Median)
-68.0% vs price
Bull Case (75th pct.)
-60.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1.15 | -97.9% | High (40%) |
| PE Comparable | $10.11 | -81.5% | Medium (25%) |
| Graham Number | $17.49 | -68.0% | Low (10%) |
| EV/EBITDA | $21.66 | -60.4% | Medium (20%) |
| EV/FCF | $31.54 | -42.3% | Medium (20%) |
Based on 5 out of 8 methods, AHR appears overvalued at the current price of $54.68. The base case fair value of $17.49 implies 68.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.